CAPLIPOINT
Caplin Point Laboratories Limited
Healthcare
Share price
₹2,680
Market cap
₹20,365 Cr
1Y return
▲ 33%
A pharmaceutical manufacturer engaged in producing active pharmaceutical ingredients and finished formulations with integrated research and development capabilities. Caplin Point Laboratories operates across multiple geographies including Latin America, Africa, and the United States, serving both domestic and international markets. The company combines API manufacturing with clinical research operations, positioning itself as a vertically integrated player in the global healthcare sector with a diverse product portfolio.
Recent moves 1
UTI Mutual FundDecreased
UTI Mutual Fund decreased its stake in Caplin Point Laboratories from 1.85% to 1.81%, selling 30,340 shares. This transaction is valued at approximately ₹7.58 Cr based on the share price of ₹2499.70.
Read more
Track the whales in Caplin Point Laboratories Limited
Get alerted the moment a top investor buys or sells.
Get started